Biospecimen Quality For Precision Medicine
September 27, 2018
CloudLIMS hosted a complimentary webinar on “Biospecimen Quality For Precision Medicine” and received an overwhelming response. A large number of attendees attended the live webinar. The webinar was presented by Dr. Jim Vaught, Editor-in-Chief of Biopreservation and Biobanking (BIO), the official journal of ISBER. We received several interesting questions from the attendees and it was a great experience interacting with them.
Precision medicine has the potential to significantly improve patient care by providing personalized treatments to patients. Human biospecimens are integral for precision medicine research, which aims at developing personalized medicine based on an individual's genetic makeup, environment, demographic factors, and lifestyle. High-quality, properly annotated, legally and ethically acquired biospecimens are indispensable for effective precision medicine research. Biobanks not only provide human biospecimens such as tissue, blood, and other bodily fluids to researchers but also provide associated clinical and molecular metadata, which is crucial for biomedical research, drug discovery, and precision medicine advancement.
The webinar focused on the role of biobanks in precision medicine, the challenges faced by precision medicine, the factors researchers should consider when sourcing biospecimens from biobanks, and the key elements of maintaining biospecimen quality. The webinar also highlighted the significance of a cloud-based biobanking LIMS in minimizing operational costs, thus improving the financial sustainability of biobanks.
If you missed the chance to attend the webinar, you can watch the video. If you would like to discuss some of the biobanking data management and regulatory challenges you face, you can sign up to talk to our experts.
Also, watch the webinar: Role of Biobanks: Challenges and Opportunities in Cancer Research.
September 14, 2018
CloudLIMS is pleased to host a complimentary live webinar titled “Biospecimen Quality For Precision Medicine” on September 25, 2018, at 1 PM EDT. The webinar will be presented by Dr. Jim Vaught, Editor-in-Chief of Biopreservation and Biobanking (BIO), the official journal of ISBER.
Each individual has a unique genetic makeup, physiology, medical history, and lifestyle. Precision medicine, also known as personalized medicine, is a new and promising approach to address an individual patient's healthcare needs by taking into account a patient's genetic and lifestyle variability. Precision medicine has the potential to revolutionize the way clinicians treat ailments and prescribe medicines, leading to a targeted and effective treatment for each patient. Biobanks provide high-quality, appropriately consented bio-specimens and associated metadata to clinicians which enable molecular characterization of the host and the disease, advancing translational research, thus driving the development of personalized medicine.
This 30-minute webinar emphasizes the significance of precision medicine, and the role of biobanks in making precision medicine a reality in the true sense. The webinar also highlights the importance of improving bio-specimen quality and the role of a biobanking LIMS in data management and in preserving bio-specimen quality, which is crucial for translational and clinical research.
Who Should Attend?Recommended attendees include laboratory directors and managers, owners, and quality managers of biobanks and clinical research laboratories.
Register for this complimentary webinar to learn more. After registration, you will receive a confirmation email with detailed instructions to join the webinar. If you have any questions or need technical assistance in joining the webinar, please contact us.
If you have any suggestions for other webinar topics, you can drop your suggestions in the comment box below. In case you are unable to attend the webinar, you can share information on this webinar with your friends and colleagues using the social media icons, just above the comment box.
Also, read the white paper titled "The Role of LIMS in Meeting Biobank Regulatory Requirements and Ensuring Operational Quality".